Zachary Rasor, DPM
Foot & Ankle Surgery · Va Beach, VANPI 1235525890
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Stryker at 46.2% of the total. Reporting peaked in 2019 at $7,145 and has fallen 94.0% since, to $428 in 2025.
Across 184 payments — averaging $79.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$7K
- Johnson & Johnson$3K
- Medical Device Business Services, Inc.$3K
- RTI Surgical, Inc$543
- Nevro Corp.$182
- Access Pro Medical, LLC$168
- plus $740 from 10 others
Across 1 payment — averaging $13,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Geistlich Pharma, North America, Inc.$13K
What the payments were for
- Consulting fees$5003%
- Travel & lodging$5,66739%
- Food & beverage$8,49958%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 79 | $6,775 |
| Johnson & Johnson | 75 | $3,496 |
| Medical Device Business Services, Inc. | 11 | $2,762 |
| RTI Surgical, Inc | 2 | $543 |
| Nevro Corp. | 2 | $182 |
| Access Pro Medical, LLC | 1 | $168 |
| Flower Orthopedics Coporation | 2 | $163 |
| Biocomposites Inc | 1 | $155 |
| Smith+Nephew | 1 | $140 |
| Kerecis Limited | 1 | $78 |
| Bioventus LLC | 2 | $69 |
| Medtronic | 2 | $50 |
| Pfizer | 2 | $30 |
| Endo USA, Inc. | 1 | $22 |
| Endo Pharmaceuticals Inc. | 1 | $20 |
| Sanara Medtech Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALLOGRAFT$3,487
- HEADLESS COMPRESSION SCREWS$1,267
- ANCHORAGE$639
- HOFFMANN$565
- Dermineralized Bone Fibers (DBF)$500
- HAMMERLOCK$476
- NA$328
- VA-LCP$325
- DYNACORD$264
- HEALIX KNOTLESS PEEK$249
- STAR$172
- AXSOS$172
- Matriderm$168
- CITREFIX$156
- PROSTEP MICA$156
- ORTHOLOC 3DI$156
- Stimulan$155
- VARIAX$152
- EX-FIX$151
- PROstep$149
How this compares
$14,666 in reported general payments places this provider in the 80th percentile of 260 foot & ankle surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $2,627 |
| Ciclopirox | 75 | $1,294 |
| Ketoconazole | 17 | $446 |
| Terbinafine Hcl | 26 | $335 |
| Cephalexin | 76 | $332 |
| Doxycycline Hyclate | 47 | $294 |
| Methylprednisolone | 48 | $257 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 31 | $139 |
| Ciprofloxacin Hcl | 16 | $96 |
| Gabapentin | 19 | $88 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $85 |
| Meloxicam | 23 | $40 |
| Oxycodone Hcl | 17 | $38 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $30 | $2,62714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 260 foot & ankle surgery providers in Virginia.
Other foot & ankle surgery in Va Beach
- Mark JonesNorth Chesterfield$2.4M
- Oliver SchipperArlington$1.2M
- Steven NeufeldFalls Church$857K
- Charles ZelenRoanoke$363K
- Ryan VazalesGlen Allen$337K
- Jugal DhariaFairfax$309K
- William SimonVirginia Beach$292K
- William GrantVirginia Beach$271K
- Bradley LevittVirginia Beach$243K
- Richard DernerLake Ridge$212K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.